Drug manufacturers Takeda Pharmaceutical and Roche could each be forced to repay the government $100 million annually for wasted medicines under the bipartisan Senate infrastructure deal.
Drugmakers Takeda Pharmaceutical Co. and Roche Holding AG could each be forced to repay the government $100 million annually for wasted medicines under the Senate infrastructure deal.
President Joe Biden quelled for now a brewing confrontation with progressive Democrats with a new moratorium on evictions during the pandemic, but the order invites a legal fight with high-stakes consequences for public health that the government may well lose.
The Centers for Disease Control and Prevention extended a ban evictions in areas of the country with substantial and high transmission of coronavirus yesterday, after a firestorm of criticism from Democrats following the lapse of a previous moratorium on Saturday.
A new program to reconnect communities split by highways would get $1 billion in the Senate infrastructure bill, just 5% of what the Biden administration initially proposed, and well below the cost of major projects.
Senate Majority Leader Chuck Schumer’s (D-N.Y.) plan to pass a $550 billion infrastructure bill this week hit a potential obstacle from a surprising source when a key Republican announced he tested positive for Covid-19 and would quarantine for 10 days.
We, and third parties, use cookies to provide website functionality, improve your user experience and to serve tailored advertisements. By clicking “Accept,” you agree to the use of cookies. Change your settings anytime by updating your
Cookie Preferences.
For more information, see our Privacy Policy.
We, and third parties, use cookies and other electronic tools to enhance your experience, analyze site usage, and deliver advertisements tailored to your interests. For more information, please read our Privacy Policy. By clicking "Save Settings", you agree to the use of these tools.
California Residents
To opt out of sharing your information for advertising purposes you can choose below under “Advertising” to opt-out of all or adjust your specific choices. You may also submit a request via this Do Not Sell My Personal Info link.
Your choice regarding cookies on this website:
Required
These cookies are required to enable core site functionality.
These cookies allow us to analyze site usage so we can measure and improve performance. They collect information in a way that does not directly identify individuals.
Advertising
We and our advertising partners use electronic technologies to collect certain types of personal information through our digital properties in order to provide you with relevant advertisements. Personal information may include your IP address, digital identifiers, and your interactions with digital properties.
Thank you, your preferences have been saved. You can change your settings anytime using the Cookie Preferences link in the footer of the website.
Thank you, your preferences have been saved. You can change your settings anytime using the Cookie Preferences link in the footer of the website.
By saving your settings you are agreeing to the use of these tools. You can change your settings at anytime using the Cookie Preferences link in the footer of this website.
